Date/Time
Date(s) - August 26, 2025 - August 29, 2025
12:00 pm
Categories
Instructed by Windshire’s President and Principal Consultant, James Blackwell, PhD, MBA
Certified through: The Center for Professional & Innovation & Education (CfPIE)
August 26 – 29, 2025 (12:00 to 5:00 ET / 9:00 to 2:00 PT)
December 8 – 11, 2025 (7:00 to 12:00 ET / 13:00 to 18:00 CET)
Join us for a comprehensive 20-hour course on CMC Regulatory Compliance Strategy for Recombinant Proteins, Monoclonal Antibodies, & Biosimilars, hosted by Windshire’s president, James Blackwell. This course is designed to help professionals involved with recombinant proteins and monoclonal antibodies (including fusion proteins, bispecific antibodies, and antibody-drug conjugates) develop an effective risk-based Chemistry, Manufacturing & Control (CMC) regulatory compliance strategy for the manufacture and control of these products.
Don’t miss this opportunity to enhance your expertise in the manufacturing and control of recombinant proteins, monoclonal antibodies, and biosimilars.